SLXN
Price
$7.74
Change
+$0.48 (+6.61%)
Updated
Aug 28 closing price
Capitalization
5.66M
VRTX
Price
$392.05
Change
+$2.97 (+0.76%)
Updated
Aug 28 closing price
Capitalization
100.52B
61 days until earnings call
Interact to see
Advertisement

SLXN vs VRTX

Header iconSLXN vs VRTX Comparison
Open Charts SLXN vs VRTXBanner chart's image
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$32.07K
Capitalization5.66M
Vertex Pharmaceuticals
Price$392.05
Change+$2.97 (+0.76%)
Volume$1.53M
Capitalization100.52B
SLXN vs VRTX Comparison Chart in %
Loading...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLXN vs. VRTX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLXN is a StrongBuy and VRTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (SLXN: $7.74 vs. VRTX: $392.05)
Brand notoriety: SLXN and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLXN: 35% vs. VRTX: 88%
Market capitalization -- SLXN: $5.66M vs. VRTX: $100.52B
SLXN [@Biotechnology] is valued at $5.66M. VRTX’s [@Biotechnology] market capitalization is $100.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 0 FA rating(s) are green whileVRTX’s FA Score has 0 green FA rating(s).

  • SLXN’s FA Score: 0 green, 5 red.
  • VRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VRTX is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 5 TA indicator(s) are bullish while VRTX’s TA Score has 6 bullish TA indicator(s).

  • SLXN’s TA Score: 5 bullish, 3 bearish.
  • VRTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VRTX is a better buy in the short-term than SLXN.

Price Growth

SLXN (@Biotechnology) experienced а +13.75% price change this week, while VRTX (@Biotechnology) price change was -1.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

VRTX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($101B) has a higher market cap than SLXN($5.66M). VRTX YTD gains are higher at: -2.645 vs. SLXN (-74.345). VRTX has higher annual earnings (EBITDA): 4.59B vs. SLXN (-17.81M). VRTX has more cash in the bank: 6.38B vs. SLXN (3.47M). SLXN has less debt than VRTX: SLXN (3.7M) vs VRTX (1.53B). VRTX has higher revenues than SLXN: VRTX (11.4B) vs SLXN (0).
SLXNVRTXSLXN / VRTX
Capitalization5.66M101B0%
EBITDA-17.81M4.59B-0%
Gain YTD-74.345-2.6452,811%
P/E RatioN/A27.88-
Revenue011.4B-
Total Cash3.47M6.38B0%
Total Debt3.7M1.53B0%
FUNDAMENTALS RATINGS
VRTX: Fundamental Ratings
VRTX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SLXNVRTX
RSI
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
10%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bullish Trend 1 day ago
27%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
30%
Bullish Trend 1 day ago
56%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
27%
Bearish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
39%
Advances
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
59%
Declines
ODDS (%)
Bearish Trend 9 days ago
76%
Bearish Trend 4 days ago
41%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
38%
Bullish Trend 1 day ago
53%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLI200.740.47
+0.23%
Houlihan Lokey
EPAC42.880.09
+0.21%
Enerpac Tool Group Corp
GMRE7.38-0.16
-2.12%
Global Medical REIT
IBG0.58-0.03
-4.51%
Innovation Beverage Group Ltd
LPSN0.94-0.15
-13.41%
LivePerson

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+6.54%
IMA - SLXN
63%
Loosely correlated
-1.32%
CELC - SLXN
50%
Loosely correlated
+9.29%
MRSN - SLXN
43%
Loosely correlated
+0.39%
CHRS - SLXN
26%
Poorly correlated
+3.51%
QSI - SLXN
25%
Poorly correlated
-0.86%
More

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
+0.76%
NEVPF - VRTX
47%
Loosely correlated
N/A
RGNX - VRTX
42%
Loosely correlated
+2.15%
SNDX - VRTX
41%
Loosely correlated
+0.37%
IDYA - VRTX
36%
Loosely correlated
-0.28%
FOLD - VRTX
35%
Loosely correlated
+0.13%
More